India Weighs Two-Year Banking Fix for Fairfax’s $5 Billion IDBI Deal

A proposed transition period could let Fairfax complete India’s largest foreign bank investment while resolving its existing stake in CSB Bank.

By Clara van Dijk • • Markets

A small and a large classical bank structure connected by a bridge through a glowing regulatory gateway

India may give Fairfax Financial up to two years to resolve a regulatory conflict that stands between the Canadian investment group and control of IDBI Bank. The proposed accommodation would allow Fairfax to complete a transaction valued at more than $5 billion and then sell or combine its existing 40% holding in CSB Bank, according to two people cited by Reuters.

The arrangement would address a basic Reserve Bank of India rule: one owner cannot operate two separate banks. Fairfax is the leading contender for the 60.7% IDBI stake being sold by India’s federal government and state-owned Life Insurance Corporation, but its CSB position means a successful bid cannot simply close without an ownership remedy.

If completed, the transaction would be the largest foreign investment in an Indian bank. It would also finish a privatisation process that began in 2022, stalled over price and liabilities, and was revived after Fairfax and Emirates NBD submitted revised bids.

The new information is important but not final. Reuters attributed the two-year allowance to two sources familiar with the matter. A separate government official described discussion of the accommodation as speculative, while Fairfax, the Indian finance ministry and the RBI did not comment. Any article about the transaction must therefore distinguish a proposed path from a granted approval.

The ownership problem

Fairfax’s India strategy already includes a substantial position in CSB Bank, a private lender with a balance sheet of roughly ₹863 billion. IDBI is much larger, with assets around $42 billion, and carries a very different institutional history. Life Insurance Corporation rescued the bank in 2019 after a rise in bad loans; the government and insurer are now seeking to sell majority control as part of a wider asset-monetisation programme.

Fairfax has two broad options. It could dispose of its CSB holding after acquiring IDBI, separating the two institutions and satisfying the single-bank rule. Or it could merge CSB into IDBI, retaining exposure to both businesses inside one licensed group.

Neither route is frictionless. A sale could force Fairfax to accept the timing and valuation available in the market. A merger would combine institutions of very different scale and could require branch, workforce, technology and product integration. Labour considerations at IDBI, as well as the need to protect depositors and minority shareholders, could make the smaller CSB business difficult to absorb quickly.

The reported two-year period would give Fairfax room to avoid a distressed disposal while allowing the state to proceed with the long-delayed privatisation. From the regulator’s perspective, however, an extended transition creates its own supervisory burden: the RBI would need to ensure that governance, capital and related-party protections remain clear while one controlling investor has economic exposure to two banks.

A deal shaped by policy as much as price

The government owns 45.48% of IDBI and LIC holds 49.24%. Together they plan to sell 60.7%, leaving the buyer with control and triggering additional public-shareholder requirements. Revised bids from Fairfax and Emirates NBD arrived after the government reduced its confidential reserve price. A panel of senior bureaucrats has reportedly cleared the transaction for final consideration by a ministerial committee, after which RBI and securities-regulator approvals would still be needed.

This is not the first report identifying Fairfax as the likely winner. Indian media in July said the group had emerged as the preferred bidder at a price near ₹81 per share. The fresh development is the possible two-year regulatory solution for its CSB ownership—not the original existence of the IDBI sale.

For New Delhi, the transaction carries fiscal and signalling value. Proceeds would support the government’s asset-sale programme at a time of pressure on public finances and the rupee. A record foreign investment in a bank would also demonstrate that India can attract long-term strategic capital into a sector where ownership and licensing rules remain tightly controlled.

For Fairfax, IDBI would be far larger than its current Indian banking exposure and could become an anchor financial-services investment. The group would gain a national deposit franchise and a platform for lending growth, but it would also inherit the execution risk attached to a former state-controlled lender and a politically sensitive privatisation.

Why it matters

The proposed two-year window shows how regulation can determine whether a transaction is executable even after bidders and sellers converge on value. India wants foreign capital and privatisation proceeds, while the RBI must preserve a clear rule against common ownership of separate banks. A transition period could reconcile those objectives without permanently relaxing the ownership standard.

The decision would be watched beyond Fairfax and IDBI. Other global banks and investment groups will treat it as evidence of how India applies its rules when a strategic investor already has a local licence or holding. A transparent, time-limited remedy could improve deal certainty; an opaque exception could create expectations of case-by-case treatment.

The immediate uncertainty is substantial. No final ministerial approval has been announced, the RBI has not confirmed the proposed timetable, and one official disputed that the accommodation was settled. The transaction should therefore be understood as advanced but conditional. Its significance lies in the potential structure: a record foreign bank investment paired with a regulatory clock for consolidating ownership.

Sources: Reuters on the proposed two-year remedy, Reuters on the revised bids, and Reuters on the original sale process.